Novavax reported 2.01 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Adma Biologics 15.02 14.71 Mar/2026
AstraZeneca 25.34 4.25 Jun/2026
BioCryst Pharmaceuticals 6.84 0.78 Jun/2026
GlaxoSmithKline 10.63 4.24 Jun/2026
MannKind 201.15 102.55 Mar/2026
Merck 32.26 15.74 Jun/2026
Moderna 27.22 14.51 Jun/2023
Novartis 21.36 3.57 Mar/2026
Novavax 2.01 1.07 Dec/2025
Pfizer 11.48 2.16 Jun/2026
Sanofi 18.96 7.12 Jun/2026
Sarepta Therapeutics 27.27 0 Mar/2026
TG Therapeutics 19.64 7.65 Jun/2026